superficial basal cell carcinoma

Known as: basal cell carcinoma superficial, multifocal basal cell carcinoma 
A variant of basal cell carcinoma of the skin presenting as erythematous, often multiple patches. Morphologically, it is characterized by the… (More)
National Institutes of Health

Related topics

Related topics

11 relations
Basal CellEpithelial CellsEpitheliumErythema
(More)

Broader (1)

Basal cell carcinoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial.
OBJECTIVES To evaluate the safety of two applications of PEP005 (ingenol mebutate) gel in superficial basal cell carcinoma… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2008
2008
Dermoscopic patterns of superficial basal cell carcinoma.
BACKGROUND Superficial basal cell carcinoma (BCC) presents as a scaly, pink to red-brown patch and is predominantly located on… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial.
This multicentre, randomized study compared photodynamic therapy using topical methyl aminolaevulinate (MAL PDT), a non-invasive… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.
OBJECTIVE To compare the efficacy and cosmetic outcome (CO) of photodynamic therapy with topical methyl aminolevulinate (MAL-PDT… (More)
  • table 1
  • table 2
  • table 4
  • table 3
Is this relevant?
2007
2007
CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.
Basal cell carcinoma and squamous cell carcinoma are common entities in clinical practice. Their distinction can be difficult… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
BACKGROUND Imiquimod is an immune response modifier that acts through toll-like receptor 7 to induce cytokine production and a… (More)
Is this relevant?
Review
2005
Review
2005
Imiquimod: in superficial basal cell carcinoma.
Imiquimod, available as a 5% cream, is a new topical treatment for adults with superficial basal cell carcinoma (BCC). The exact… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
BACKGROUND Imiquimod is an immune response modifier that is a Toll-like receptor 7 agonist that induces interferon and other… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study.
BACKGROUND Imiquimod 5% cream may provide an effective nonsurgical treatment for superficial basal cell carcinoma (sBCC) based on… (More)
  • table I
  • table II
  • figure 1
  • figure 2
  • figure 5
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial.
BACKGROUND Superficial basal cell carcinoma (sBCC) is an increasingly common tumor in fair-skinned populations throughout the… (More)
Is this relevant?